KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aehr Test Systems (AEHR) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Aehr Test Systems (AEHR) over the last 15 years, with Q4 2025 value amounting to $7.2 million.

  • Aehr Test Systems' Operating Expenses rose 405.03% to $7.2 million in Q4 2025 from the same period last year, while for Nov 2025 it was $30.8 million, marking a year-over-year increase of 2331.5%. This contributed to the annual value of $29.6 million for FY2025, which is 3180.5% up from last year.
  • Aehr Test Systems' Operating Expenses amounted to $7.2 million in Q4 2025, which was up 405.03% from $7.8 million recorded in Q3 2025.
  • Aehr Test Systems' 5-year Operating Expenses high stood at $8.3 million for Q1 2025, and its period low was $2.5 million during Q1 2021.
  • Its 5-year average for Operating Expenses is $5.4 million, with a median of $5.3 million in 2023.
  • Within the past 5 years, the most significant YoY rise in Aehr Test Systems' Operating Expenses was 6380.87% (2021), while the steepest drop was 694.44% (2021).
  • Aehr Test Systems' Operating Expenses (Quarter) stood at $3.8 million in 2021, then rose by 16.41% to $4.4 million in 2022, then increased by 24.04% to $5.5 million in 2023, then rose by 25.92% to $6.9 million in 2024, then grew by 4.05% to $7.2 million in 2025.
  • Its Operating Expenses was $7.2 million in Q4 2025, compared to $7.8 million in Q3 2025 and $7.5 million in Q2 2025.